ATE76293T1 - Glukosetoleranzfaktor und dessen herstellung. - Google Patents

Glukosetoleranzfaktor und dessen herstellung.

Info

Publication number
ATE76293T1
ATE76293T1 AT86907204T AT86907204T ATE76293T1 AT E76293 T1 ATE76293 T1 AT E76293T1 AT 86907204 T AT86907204 T AT 86907204T AT 86907204 T AT86907204 T AT 86907204T AT E76293 T1 ATE76293 T1 AT E76293T1
Authority
AT
Austria
Prior art keywords
glucose tolerance
tolerance factor
production
biogel
factor
Prior art date
Application number
AT86907204T
Other languages
English (en)
Inventor
David Hwang
Arye Lev-Ran
Ken Barseghian
Original Assignee
Anheuser Busch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anheuser Busch filed Critical Anheuser Busch
Application granted granted Critical
Publication of ATE76293T1 publication Critical patent/ATE76293T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Quinoline Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT86907204T 1985-11-21 1986-11-19 Glukosetoleranzfaktor und dessen herstellung. ATE76293T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79597785A 1985-11-21 1985-11-21
PCT/US1986/002493 WO1987003200A1 (en) 1985-11-21 1986-11-19 Glucose tolerance factor and method of making same
EP86907204A EP0248057B1 (de) 1985-11-21 1986-11-19 Glukosetoleranzfaktor und dessen herstellung

Publications (1)

Publication Number Publication Date
ATE76293T1 true ATE76293T1 (de) 1992-06-15

Family

ID=25166930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86907204T ATE76293T1 (de) 1985-11-21 1986-11-19 Glukosetoleranzfaktor und dessen herstellung.

Country Status (8)

Country Link
EP (1) EP0248057B1 (de)
JP (1) JPH0686379B2 (de)
AT (1) ATE76293T1 (de)
AU (1) AU6728687A (de)
CA (1) CA1282786C (de)
DE (1) DE3685438D1 (de)
DK (1) DK379187A (de)
WO (1) WO1987003200A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95220A0 (en) * 1989-07-28 1991-06-10 Thymax Corp Dithiochrome,an insulinbinding molecule,pharmaceutical compositions containing it and methods for extracting it
TW304945B (de) * 1992-06-27 1997-05-11 Hoechst Ag
US20060029642A1 (en) 2004-08-03 2006-02-09 Dusan Miljkovic Methods and compositions for improved chromium complexes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES472034A1 (es) * 1978-07-26 1979-02-16 Consejo Superior Investigacion Sintesis de un nuevo factor de tolerancia a la glucosa
US4343905A (en) * 1980-07-07 1982-08-10 Andrew Szalay Concentrated GTF chromium complex brewers yeast and process for producing same

Also Published As

Publication number Publication date
EP0248057A1 (de) 1987-12-09
DE3685438D1 (de) 1992-06-25
CA1282786C (en) 1991-04-09
JPH0686379B2 (ja) 1994-11-02
EP0248057A4 (de) 1988-06-23
WO1987003200A1 (en) 1987-06-04
DK379187D0 (da) 1987-07-21
AU6728687A (en) 1987-07-01
EP0248057B1 (de) 1992-05-20
DK379187A (da) 1987-07-21
JPS63501424A (ja) 1988-06-02

Similar Documents

Publication Publication Date Title
AU7173887A (en) Lymphokines to treat bacterial infections in mammals
IE872799L (en) Peptide preparation
GR3005297T3 (de)
DE3561472D1 (en) Process for the extraction of poly-beta-hydroxybutyrates with a solvent from an aqueous suspension of microorganisms
AU583683B2 (en) Yeast production of hepatitis B surface antigen
EP0251584A3 (de) Synchronisationsverwaltung für ein verteiltes Betriebssystem oder ähnliche Systeme
AU1520088A (en) Simplified method for the preparation of human lymphokine activated killer cells
AU8171987A (en) Blood separator
NO179074C (no) Fremgangsmåte for fremstilling av rensede glykolipider ved membranadskillelsesfremgangsmåten
DZ743A1 (fr) Nouveaux dérivés de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procédé de préparation.
US4533548A (en) Acidic polysaccharide CH-1 isolated from Chlorella pyrenoidosa and the use thereof
PL285552A1 (en) Method for manufacturing a thermally stable citozin dezamine
EP0249194A3 (de) Topische Prostaglandinzusammensetzungen
AU7010487A (en) Improvements relating to the production of beer
ATE210673T1 (de) Glycokonjugate von modifizierten camptothecin- derivaten (20-o-verknüpfung)
FR2366290A1 (fr) Nouvelles 1h-pyrazolo (3,4-b) pyridines, leur preparation et medicaments les renfermant
ES8407064A1 (es) "procedimiento para la preparacion de compuestos de la serie de los glicolipidos regeneradores de celulas y tejidos"
CA2092720A1 (en) Macrophage activating factor from vitamin d binding protein
ATE272648T1 (de) Glycokonjugate von 20(s)-camptothecin
DE3685438D1 (de) Glukosetoleranzfaktor und dessen herstellung.
GB8506454D0 (en) Camomile extracts
FI853228A0 (fi) Nya -butyrolaktamer, deras farmaceutiskt aktiva kompositioner, foerfaranden foer deras framstaellning och deras anvaendning som laekemedel.
WO1999064439A3 (en) Methods for increasing cationic antimicrobial peptides
AU7382087A (en) Rapid detection of N. gonorrhoeae without culture
AU7684787A (en) Throttle body with centrifugal injector

Legal Events

Date Code Title Description
EEFA Change of the company name
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee